APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our January/February issue:

FEATURED

Salary & Satisfaction: Industry Jobs Survey
Lisa Henderson
The perfect storm of R&D and innovation growth, job opportunity and demand, and other workplace trends is translating to solid salary and satisfaction levels among clinical research professionals, a new ACT and SCORR Marketing survey finds.

Cardiac Imaging in Oncology Trials
Joseph Pierro, MD, Robert Kleiman, MD
Cardiac imaging is commonly used as a biomarker for safety in oncology drug development. Authors outline how advanced imaging management systems can allow for the identification of potential pathological changes earlier and have broader implications for patient safety and trial cost and timing.

Technology and Compassionate Use
Richard Stroder, Scott Shaunessy
Due to the relatively low volume of compassionate use requests from HCPs, many pharma companies rely on ad hoc processes for intake and decision-making, which can be inefficient and protracted. A case study presents best practices in implementing a technology-based process for handling and managing compassionate use requests.

Are GCP Refreshers Effective?
Yoong Kai Shen, Joanne Yeoh
Survey findings assess the impact of Clinical Research Malaysia’s good clinical practice refresher workshops in retraining investigators and allied health professionals on the latest guidelines.

NEWS

Washington Report: Jill Wechsler explores the notable gains in new-drug approvals based on accelerated review programs.

EU Report: Peter O’Donnell on the persistent struggles in complying with clinical trial reporting requirements—and how social media is highlighting these gaps.

Q&A: How one emerging biopharma company is navigating the challenges in developing drugs for very rare conditions.

CLOSING THOUGHT

Budding Drug Class: Knowledge Gaps
Meghan Oates-Zalesky
Despite the buzz generated by recent approvals and progress in the pipeline, physicians have limited familiarity and understanding with the burgeoning category of nucleic acid-based therapies.
View the digital Issue
image
 
BLOGS
To Extrapolate Site Enrollment or Not To Extrapolate? That is the Question
The Future of Clinical Trials: Predictions for 2020
Coronavirus Offers Opportunities and Challenges for Biopharma R&D
WEBCAST
The Current and Future Impact of AI on Pharmacovigilance
Learn about potential ways artificial intelligence and machine learning can impact how pharmacovigilance is performed—from individual adverse event processing using data analytics and signal detection, to predictive analysis and data mining.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.

Twitter LinkedIn